ITGAM and Miyoshi myopathy: In a comprehensive approach that integrated clinical, functional, and molecular data on granulocytic cells from the TME, Pérez et al. [123] identified a set of markers (CD11b/CD13/CD16) for optimal monitoring of granulocytic MDSCs in MM that was evaluated in BM samples from both controls and MM patients using multi-dimensional FCM.